SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-001631
Filing Date
2015-03-13
Accepted
2015-03-13 06:03:02
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q nvet-10q_20141231.htm 10-Q 2224057
2 EX-3.1 nvet-ex31_20141231226.htm EX-3.1 448967
3 EX-31.1 nvet-ex311_201412311601.htm EX-31.1 9641
4 EX-31.2 nvet-ex312_201412311598.htm EX-31.2 9562
5 EX-32.1 nvet-ex321_201412311599.htm EX-32.1 7163
6 EX-32.2 nvet-ex322_201412311600.htm EX-32.2 7164
  Complete submission text file 0001564590-15-001631.txt   9925087

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT nvet-20141231.xml EX-101.INS 1460666
8 XBRL TAXONOMY EXTENSION SCHEMA nvet-20141231.xsd EX-101.SCH 53959
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvet-20141231_cal.xml EX-101.CAL 27046
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvet-20141231_def.xml EX-101.DEF 166408
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvet-20141231_lab.xml EX-101.LAB 375543
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvet-20141231_pre.xml EX-101.PRE 302060
Mailing Address NATL INST FOR BIOPROCESSING RESEARCH FOSTERS AVENUE, MOUNT MERRION BLACKROCK CO. DUBLIN L2 00000
Business Address NATL INST FOR BIOPROCESSING RESEARCH FOSTERS AVENUE, MOUNT MERRION BLACKROCK CO. DUBLIN L2 00000 353 1 215 8100
Nexvet Biopharma plc (Filer) CIK: 0001618561 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36828 | Film No.: 15697643
SIC: 2834 Pharmaceutical Preparations